In a bold stride towards redefining rare disease treatment, Burjeel Holdings has officially launched the Genetics and Rare Disease Centre at Burjeel Medical City in Abu Dhabi—and it’s not just another clinic, it’s a full-on revolution in care. Think of it as the Avengers headquarters for battling rare and genetic conditions, only with world-class doctors, cutting-edge science, and a whole lot of heart.
This powerhouse facility is tackling the often-overlooked world of rare diseases, which may individually affect only a small number of people, but collectively impact millions—especially across the MENA region. With over 40 million individuals in the region affected by rare conditions, this centre isn’t just timely—it’s critical. Burjeel’s game plan? Break down the barriers of diagnosis delays, lack of awareness, and fragmented care systems with an all-in-one solution that offers patients integrated, multidisciplinary services under one ultra-modern roof.
Led by global genetics guru Professor Ayman El-Hattab and backed by a superstar team including Prof. Khaled Musallam and Prof. Faisal Khan, the centre is split into three core units: clinical care, research and trials, and community education. Whether it’s cancer genetics, neurogenetics, or prenatal care, the Clinical Care Unit is all about delivering precise, personalized treatment. Meanwhile, the Innovative Trials Unit brings global research to the region’s doorstep, offering patients early access to promising therapies. And it doesn’t stop there—the Social Integration and Education Unit is going grassroots with awareness campaigns, seminars, and outreach to both medical pros and the public.
This isn’t just about medicine—it’s about creating a movement. Burjeel Holdings’ CEO, John Sunil, describes it as a mission to bridge the gap between need and access, science and compassion. And with this centre, Abu Dhabi isn’t just stepping into the future of healthcare—it’s sprinting.
So yes, genes might be complicated, but this message isn’t: Abu Dhabi just leveled up in the fight against rare diseases, and the world should take note.
